期刊文献+

埋藏式心脏复律除颤器在心脏性猝死一级预防中的作用 被引量:9

Evaluation of implanted cardioverter-defibrillators for primary prevention of sudden cardiac death
在线阅读 下载PDF
导出
摘要 目的探讨埋藏式心脏复律除颤器(ICD)在心脏性猝死(SCD)一级预防中的作用。方法对35例在2006~2009年根据2005年ACC/AHC指南植入ICD进行SCD一级预防的患者,进行平均2年的临床随访数据分析。结果 (1)平均2年随访过程中,共11例患者(31.43%)发生室性心律失常事件,室颤除颤16阵次、室速启动抗心动过速起搏(ATP)79阵次,无误放电,无一例死亡;(2)室性心律失常事件,心肌致密化不全(NVM)发生率为100%、特发性室性心动过速(PVT)66.67%、Brugada综合征50%、肥厚型心肌病(HCM)25%和(DCM)16.67%;其中室颤PVT占87.5%(14阵次),DCM及Brugada综合征各1阵次;室速PVT占82.28%(65阵次)、NVM 5阵次、HCM和Brugada综合征各4阵次和DCM患者1阵次,致心律失常右室心肌病未见室性心律失常事件;(3)术中术后未见植入ICD相关并发症,术后均未出现恶性室性心律失常所致晕厥,生活质量明显改善。结论本组SCD高危患者中,平均ICD植入两年即在31.43%的患者中及时发现和纠正95次的恶性室性心率失常事件,其中对预防PVT、NVM和Brugada综合征的SCD最为明显,提示SCD高危人群中植入ICD进行一级预防有重要的临床价值。 Objective To evaluate the clinical effect of implanted cardioverter-defibrillators(ICD) for primary prevention of sudden cardiac death.Methods According to ACC/AHA Guideline of ICD implantation(2005),35 patients successfully received ICD/CRT-D implantation for primary prevention of sudden cardiac death in our hospital from January 2006 to December 2009.All the patients were followed up for a mean of 2 years.Results During the follow up,11(31.43%) patients experienced entricular arrhythmic episodes,for which 16 defibrillation therapies and 75 anti-tachycardia pacing(ATP) therapies were delivered without mistaken shock or death.The incidence rate of NVM was 100%,that of PVT was 66.67%,Brugada syndrome 50%,HCM 25% and DCM 16.67%.Of these episodes,the incidence of VF episodes among PVC patients was 87.5%(14 beats),ventricular tachycardia PVC was 82.28%(65 times),5 beats in NVM patients,4 beats in HCM and Brugada syndrome patients,and 1 beat in DCM patients.No ICD implantation-related complication was detected,and no ventricular tachycardia induced syncope occurred in these cases.All patients showed improved quality of life after the implantation.Conclusions ICD implantation can prevent malignant ventricular arrhythmia episodes,especially for PVT,NVM and Brugada syndrome in high risk SCD patients,demonstrating the value of implantation of ICD as a primary prevention in high-risk SCD patients.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2013年第8期1229-1231,共3页 Journal of Southern Medical University
基金 广东省科技基金(2011B061300072)
关键词 埋藏式心脏复律除颤器 心脏性猝死 一级预防 室性心律失常 implanted cardioverter-defibrillators sudden cardiac death primary prevention malignant ventricular arrhythmia
作者简介 刘烈,副主任医师,E-mail:lie_jiu@hotmail.com 通信作者:陈东骊,副主任医师,硕士,E-mail:chendongliqq@163.com
  • 相关文献

参考文献13

  • 1Santini M,Lavalle C,Ricci RP.Primary and secondary prevention of sudden cardiac death:who should get an ICD?[J].Heart,2007,93(11):1478-83.
  • 2Sacher F,Probst V,Iesaka Y,et al.Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome:a multicenter study[J].Circulation,2006,114(22):2317-24.
  • 3Rea TD,Helbock M,Perry S,et al.Increasing use of cardiopulmonary resuscitation during out-of-hospital ventricular fibrillation arrest:survival implications of guideline changes[J].Circulation,2006,114(25):2760-5.
  • 4Bardy GH,Lee KL,Mark DB,et al.Sudden cardiac death in heart failure(SCD-HeFT) investigators.Amiodarone or an implantable cardioverter defibrillator for congestive heart failure[J].N Engl J Med,2005,352(3):225-37.
  • 5Passman R,Kadish A.Sudden death prevention with implantable devices[J].Circulation,2007,116(5):561-571.
  • 6Yap Y,Duong T,Bland M,et al.Left ventricular ejection fraction in the thrombolytic era remains a powerful predictor of long-term but not short term all cause,cardiac and arrhythmic mortality after myocardial infarction-a secondary meta-analysis of 2828 patients[J].Heart,2000,83:55.
  • 7Klein MH,Gold MR.Use of traditional and biventricular implantable cardiac devices for primary and secondary prevention of sudden death[J].Cardiol Clin,2008,26(3):419-31.
  • 8Hunt SA.ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure)[J].Circulation,2005,46(6):e1-82.
  • 9Hua W,Zhang LF,Wu YF,et al.Incidence of sudden cardiac death in China:analysis of 4 regional populations[J].J Am Coil Cardiol,2009,54(12):1110-8.
  • 10Proclemer A,Ghidina M,Gregori D,et al.Impact of the main implantable cardioverter-defibrillator trials in clinical practice:data from the Italian ICD Registry for the years 2005-07[J].Europace,2009,11(4):465-75.

二级参考文献16

  • 1Epstein A, Dimarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities[J]. J Am Coil Cardiol, 2008, 51(21) :el.
  • 2Huikur H, Castellanos A, Myerburg RJ. Sudden death due to cardiac arrhythmias[J]. N Engl J Meal, 2001, 345(20): 1 473.
  • 3The Antiarrhythmics versus Implantable Defibrillator (AVID) Investigators. A comparison of antiarrhythmie-drug therapy with implant- able defibrillators in patients resuscitated from near-fatal ventricular arrhythmias[ J]. N Engl J Med,1997 ,337 :1 576.
  • 4Kuck KH, Cappato R, Siebels J, et al. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH) [ J ]. Circulation,2000,102:748.
  • 5Buxton AE, Lee KL, Fisher JD, et al. A randomized study of the prevention of sudden death among patients with coronary artery dis- ease[J]. N Engl J Med,1999,341:1 882.
  • 6Kadish A, Dyer A, Daubert JP, et al. Prophylactic defibrillator im- plantation in patients with nonischemic dilated cardiomyopathy [ J 1. N Engl .1 Med.2004 .350 :2 151.
  • 7Myerburg R J, Kessler KM, Estes D, et al. Long-term survival after prehospital cardiac arrest : analysis of outcome during an 8 year study [ J]. Circulation, 1984,70:538.
  • 8Poole JE, Johnson GW, Hellkamp AS, et al. Prognostic importance of defibrillator shocks in patients with heart failure [ J ]. N Engl J Med ,2008,359 : 1 009.
  • 9Connolly SJ, Dorian P, Roberts RS, et al. Comparison of beta- blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Stud- y : a randomized trial[ J]. JAMA,2006,295 : 165.
  • 10Reddy VY, Reynolds MR, Neuzil P, et at. Prophylactic catheter ablation for the prevention of defibrillator therapy [ J ]. N Engl J Med ,2007,357:2 657.

共引文献7

同被引文献78

引证文献9

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部